$CBT

CABOT CORP (CBT): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

CABOT CORP (CBT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 d25963dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 TRANSITION AGREEMENT THIS TRANSITION AGREEMENT (this “ Agreement ”) is entered into as of the 29 th day of July, 2026, by and between Cabot Corporation (“ Cabot ” or the “ Company ”) and Sean D. Keohane (“ Keohane ”). WHEREA

Original reporting
Published Jul 30, 2026, 12:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 1:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$CBT
Neutral
medium confidence
Mentioned
$CBT
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CBTNeutralLow
01

Why it matters

The agreement specifies compensation during the transition period and modifies incentive eligibility for fiscal 2027, while detailing how outstanding stock options and restricted stock units are treated upon retirement.

02

Market read

This is a governance and compensation disclosure. It may cause short-term sentiment movement but lacks new financial or strategic catalysts in the excerpt.

03

What to watch

Traders may want to watch for any separate 8-Ks naming the successor CEO and detailing interim leadership responsibilities, which are not included in the provided excerpt.

Relevance 6/10Novelty 5/10Timing: filed today, effective transition date Sept. 30, 2026

Background

Cabot filed an SEC 8-K (Item 5.02) describing the retirement transition of Sean D. Keohane as President and CEO and as a director, effective Sept. 30, 2026, with continued employment through Dec. 31, 2026.

Company-level read

Ticker impact

$CBTNeutralMedium confidence
Context

Cabot discloses a CEO and director retirement effective Sept. 30, 2026, plus a transition agreement and equity retirement vesting treatment.

Expected impact

Low immediate impact; any reaction is likely modest and sentiment-driven around leadership transition and equity treatment details.

Evidence & confidence

An 8-K Item 5.02 transition agreement changes executive roles and outlines equity vesting/forfeiture mechanics, but it does not include new operating guidance, financial results, or a strategic transaction.

Market effects

Minimal sector read-through; this is company-specific leadership and compensation structuring.

None indicated.

None indicated.

Counterpoint

The equity retirement vesting and forfeiture details could still affect insider selling expectations and near-term sentiment, even without operational news.

Key entities

  • Cabot Corporation

    Company filing the 8-K and entering the transition agreement.

  • Sean D. Keohane

    Retiring President and CEO, resigning effective Sept. 30, 2026, and serving as special advisor through Dec. 31, 2026.

Related articles

$CBTMed

Cabot Corporation Q3 2026 Earnings Call Summary

Cabot Corp reported Q3 2026 results driven by a 19% year-over-year EBIT rise in Performance Chemicals. Reinforcement Materials saw lower gross profit per ton despite 5% higher volumes, tied to 2026 tire customer agreement headwinds. Adjusted EPS guidance for FY2026 was tightened to $6.15–$6.45, and Cabot plans a $125 million brownfield battery capacity expansion. CEO transition is planned.

$CBTMed

Cabot Corp (CBT) (Q3 2026) Earnings Call Highlights: Strong Performance Chemicals Growth

Cabot Corp (CBT) reported Q3 fiscal 2026 earnings call highlights, citing growth in Performance Chemicals and battery materials. Reinforcement Materials EBIT fell to $97 million from $128 million year over year, with a modest Q4 sequential decline expected. The company expects Performance Chemicals margins to normalize as raw material costs catch up to Q3 pricing. It updated its FY2026 tax rate to 28% to 30% and said it plans to resume buybacks in Q4.

$CBTMed

Cabot reports fiscal Q3 net income of $6 million

Cabot Corporation (CBT) reported fiscal Q3 2026 net sales and other operating revenues of $982 million, up from $923 million a year earlier. Net income attributable to Cabot fell to $6 million, or $0.12 diluted EPS, from $101 million. Adjusted EPS was $1.67, and guidance was tightened to $6.15 to $6.45 for fiscal 2026. CEO change announced for Oct. 1, 2026.

$CBTHigh

CABOT CORP (CBT): Results of Operations and Financial Condition

CABOT CORP (CBT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cbt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Investor Contact: Robert Rist (617) 342-6374 CABOT CORPORATION REPORTS THIRD QUARTER FISCAL YEAR 2026 RESULTS Third Quarter 2026 Diluted earnings per share (“EPS”) of $0.12 and Adjusted EPS of $1.67 BOSTON (August 3, 2026) --

$CBTMed

Why is Cabot stock sliding today?

Cabot Corporation shares fell about 4.9% in morning trading after the company said CEO Sean Keohane will retire effective Sept. 30, 2026, with CFO Erica McLaughlin becoming President and CEO on Oct. 1. The change comes four days before Cabot’s Q3 fiscal 2026 results on Aug. 3, with analysts expecting about $1.66 EPS.